Installment plans and refunds for treatments that don’t work are two options getting more attention as ultra-expensive therapies become more common. The financial strains will only grow. Read and hear … Read More
FoCUS Design Lab
Invitation-only Design Lab to further discussions/implementation from the April 2018 Design Lab
Cell & Gene Meeting on the Mesa
Colin Young, FoCUS, presenting a poster on Pipeline Research
American Society of Gene & Cell Therapy Value Summit
Mark TrusheimASGCT Value Summit
FoCUS Research Team interviewed for article on Innovating Payment Models
The leads of the FoCUS Research Teams, Strategic Director Mark Trusheim, Research Advisor Casey Quinn, Director of Simulation & Policy Research Daniel Mytelka, and Director of Drug Development Pipeline Research … Read More
FoCUS responds to HHS “Blueprint” Request for Information
Federal initiative seeks to make access to innovative therapies wider and more financially sustainable On May 16, 2018 the US Department of Health and Human Services (HHS) published a … Read More
ISPOR
Jane Barlow for FoCUS
Precision Financing strategies explored in FoCUS Design Lab
Healthcare innovation stakeholders co-develop solutions to make curative therapies accessible to patients, propose new pilot project CAMBRIDGE, MASSACHUSETTS—The NEWDrug Development ParadIGmS (NEWDIGS) initiative at the MIT Center for Biomedical Innovation (CBI) hosted … Read More
FoCUS Project: Recent International Event Highlights (April 2018)
NEWDIGS FoCUS project leaders have appeared in three recent meetings to share emerging perspectives on financing potentially durable but expensive new therapies. Casey Quinn and R. John Glasspool speak at … Read More
- Page 2 of 2
- 1
- 2